As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That ...
GLP-1 class of weight loss and diabetes drugs are linked to previously unrecognized health risks and benefits, according to a ...
As GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro gain popularity for weight loss, doctors are observing a ...
Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions ...
Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some kinds of ...
Over 2 million people were included in new research to test these drugs against 175 different health outcomes.
With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.